# Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis

> **NCT00771758** · PHASE3 · COMPLETED · sponsor: **Ortho-McNeil Janssen Scientific Affairs, LLC** · enrollment: 108 (actual)

## Conditions studied

- Back Pain

## Interventions

- **DRUG:** oxycodone IR
- **DRUG:** placebo
- **DRUG:** tapentadol IR

## Key facts

- **NCT ID:** NCT00771758
- **Lead sponsor:** Ortho-McNeil Janssen Scientific Affairs, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2014-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00771758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00771758, "Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00771758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*